Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathways - PubMed (original) (raw)
. 2003 Sep-Oct;2(5):544-51.
doi: 10.4161/cbt.2.5.454.
Affiliations
- PMID: 14614324
- DOI: 10.4161/cbt.2.5.454
Free article
Induction of apoptosis in BCR/ABL+ cells by histone deacetylase inhibitors involves reciprocal effects on the RAF/MEK/ERK and JNK pathways
Chunrong Yu et al. Cancer Biol Ther. 2003 Sep-Oct.
Free article
Abstract
Signal transduction events regulating induction of apoptosis by the histone deacetylase inhibitors (HDIs) sodium butyrate (SB) and SAHA have been examined in Bcr/Abl+ human leukemia cells (K562, LAMA 84). Exposure of K562 cells to greater or less than 3.0 mM SB or 3.0 mM SAHA for 24-48 hr resulted in a marked induction of mitchondrial damage (e.g., cytochrome c release) and apoptosis, events associated with downregulation of Bcr/Abl and Raf-1, induction of p21CIP1, inactivation of MEK1/2, ERK1/2, and p70S6K, and a dramatic increase in JNK activation. HDI-mediated apoptosis was attenuated by pharmacologic JNK inhibitors and enhanced by the MEK1/2 inhibitor U0126 as well as by the JNK activator anisomycin. Interestingly, HDI-induced JNK activation was potentiated by pharmacologic MEK inhibition. Furthermore, HDI lethality was significantly diminished in cells ectopically expressing constitutively active MEK1, confirming a functional role for MEK/ERK inactivation in HDI-mediated apoptosis. Similar events were observed in Bcr/Abl+ LAMA 84 cells. Lastly, the free radical scavenger L-N-acetylcysteine (LNAC) attenuated HDI-mediated ROS generation, JNK activation, and apoptosis. Together, these findings support a model in which induction of apoptosis in Bcr/Abl+ cells by HDIs involves coordinate inactivation of the cytoprotective Raf/MEK/ERK pathway in conjunction with the ROS-dependent activation of JNK.
Similar articles
- Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.
Yu C, Rahmani M, Almenara J, Subler M, Krystal G, Conrad D, Varticovski L, Dent P, Grant S. Yu C, et al. Cancer Res. 2003 May 1;63(9):2118-26. Cancer Res. 2003. PMID: 12727828 - Coadministration of UCN-01 with MEK1/2 inhibitors potently induces apoptosis in BCR/ABL+ leukemia cells sensitive and resistant to ST1571.
Yu C, Dai Y, Dent P, Grant S. Yu C, et al. Cancer Biol Ther. 2002 Nov-Dec;1(6):674-82. doi: 10.4161/cbt.319. Cancer Biol Ther. 2002. PMID: 12642693 - The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571.
Yu C, Rahmani M, Conrad D, Subler M, Dent P, Grant S. Yu C, et al. Blood. 2003 Nov 15;102(10):3765-74. doi: 10.1182/blood-2003-03-0737. Epub 2003 Jul 31. Blood. 2003. PMID: 12893773 - Histone deacetylase inhibitors in cancer therapy.
Rosato RR, Grant S. Rosato RR, et al. Cancer Biol Ther. 2003 Jan-Feb;2(1):30-7. doi: 10.4161/cbt.190. Cancer Biol Ther. 2003. PMID: 12673114 Review.
Cited by
- Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance.
Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton JA, Huang P, Giles FJ, Cleveland JL. Carew JS, et al. Blood. 2007 Jul 1;110(1):313-22. doi: 10.1182/blood-2006-10-050260. Epub 2007 Mar 15. Blood. 2007. PMID: 17363733 Free PMC article. - Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors.
Ungerstedt JS, Sowa Y, Xu WS, Shao Y, Dokmanovic M, Perez G, Ngo L, Holmgren A, Jiang X, Marks PA. Ungerstedt JS, et al. Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):673-8. doi: 10.1073/pnas.0408732102. Epub 2005 Jan 6. Proc Natl Acad Sci U S A. 2005. PMID: 15637150 Free PMC article. - Autophagic and apoptotic effects of HDAC inhibitors on cancer cells.
Rikiishi H. Rikiishi H. J Biomed Biotechnol. 2011;2011:830260. doi: 10.1155/2011/830260. Epub 2011 May 18. J Biomed Biotechnol. 2011. PMID: 21629704 Free PMC article. Review. - Antagonistic effects of sodium butyrate and N-(4-hydroxyphenyl)-retinamide on prostate cancer.
Kuefer R, Genze F, Zugmaier W, Hautmann RE, Rinnab L, Gschwend JE, Angelmeier M, Estrada A, Buechele B. Kuefer R, et al. Neoplasia. 2007 Mar;9(3):246-53. doi: 10.1593/neo.06766. Neoplasia. 2007. PMID: 17401464 Free PMC article. - ERK2 and JNK1 contribute to TNF-α-induced IL-8 expression in synovial fibroblasts.
Namba S, Nakano R, Kitanaka T, Kitanaka N, Nakayama T, Sugiya H. Namba S, et al. PLoS One. 2017 Aug 14;12(8):e0182923. doi: 10.1371/journal.pone.0182923. eCollection 2017. PLoS One. 2017. PMID: 28806729 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous